NCT06800313
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06800313
Title A Study of HLD-0915 in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Halda Therapeutics OpCo, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE RECRUITING Denver Colorado 80218 United States Details
Yale - New Haven Hospital - Yale Cancer Center RECRUITING New Haven Connecticut 06520 United States Details
Florida Cancer Specialists RECRUITING Sarasota Florida 34232 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
START Midwest, LLC RECRUITING Grand Rapids Michigan 49546 United States Details
Evelyn H. Lauder Breast and Imaging Center (BAIC) RECRUITING New York New York 10065 United States Details
Carolina Urologic Research Center, LLC RECRUITING Myrtle Beach South Carolina 29572 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
NEXT Austin RECRUITING Austin Texas 78758 United States Details
The University of Texas M.D. Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Royal Marsden Hospital RECRUITING Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field